Australia, Sept. 15 -- Novo Nordisk A.S, owns the trademark (2639134) for 'Kyinsu' till Feb. 13, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases.]
Type of Mark: Word
Date of Acceptance: April 21
Registration Advertised: Sept. 14
For further details contact Novo Nordisk A.S .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2639134.
Disclaimer: Curated by HT Syndication.
